As soon as pediatric neurologist Lisa Sun got the call from
an emergency department (ED) physician describing a 9-year-old patient’s
ischemic stroke-like symptoms and the time of their onset, she was out the
door. Sun and pediatric neurologist Ryan Felling, director of the Johns Hopkins
Pediatric Stroke Program, were looking for a candidate for tissue plasminogen
activator (tPA) treatment and this young patient appeared to meet the criteria.
Now they had to rush to the ED to assess the patient and confirm their
suspicions. There was no time to lose—the clock was ticking.
“You have to use this medicine within 4 1/2 hours of the
onset of symptoms, before the risk of the treatment becomes greater than its
benefit,” Sun says.
At the ED, Sun and Felling learned from Melissa Schober that
her daughter, Ruth, felt dizzy during afternoon recess at school and then
stumbled after making it inside to the cafeteria. “Her friends said she was
slurring her words and lurching from side to side,” says Schober, of Baltimore.
“Her right leg just stopped working.”
When Ruth arrived at the pediatric ED around 5 p.m. as a
trauma patient, Sun says, she was slurring her speech and weak on one side.
Seeing no sign of trauma, the ED activated its pediatric Brain Attack Team, or
BAT, and summoned Sun and Felling. Now with their young patient in front of
them and MRI results in hand revealing an occlusion in her middle cerebral
artery, the pediatric neurologists could see that their patient’s condition had
declined further.
“The MRI showed she was having a stroke at the time, a small
area of stroke and a much larger area at risk for stroke because it was not
getting enough blood flow,” says Sun. “We were concerned that the area at risk
was going to indolently die.”
Considering their patient’s worsening symptoms and the onset
of her symptoms three hours and 40 minutes earlier—well within the 4 1/2-hour
window for tPA—Sun and Felling informed Schober that Ruth was eligible for the
treatment. The therapy, they explained, has been shown to dissolve clots and
improve blood flow in patients with ischemic stroke, reducing their risk of
neurologic deficits. They added that tPA comes with a risk of bleeding,
particularly for patients with signs of bleeding in the brain. Fortunately for
Ruth, there were no such signs. Again, they noted that time was of the essence.
“Our goal was to determine whether we could give tPA, would
it be safe and reasonable,” says Sun. “We also know it’s more effective and
safer the sooner you give it.”
Schober and her husband quickly agreed with the treatment
plan and the Johns Hopkins tPA protocol for children, modeled after the Johns
Hopkins adult stroke protocol and the stroke thrombolysis in pediatric stroke
protocol designed by the National Institute of Neurological Disorders and
Stroke. Right away, Ruth began receiving tPA intravenously. How did she
respond?
Even during the one-hour infusion, Sun notes, Ruth started
showing signs of improvement: “She started moving her right side and her speech
got better.”
For Schober, the first sign of a positive change in Ruth
came the next day when Ruth was able to move her right leg. On Day Three, she
adds, Ruth, with the help of a physical therapist, was able to get out of bed.
After a 10-day admission in the hospital, she moved over to neighboring Kennedy
Krieger Institute for two weeks of rehabilitation. How is she doing today?
“She’s in school and very functional,” says Sun. “She has a
little bit of weakness on her right side still, but overall she’s able to do
almost everything she did before.”
Schober agrees: “It’s been good. She still has some
right-sided weakness, which has affected her right hand, but she is learning
how to use her left hand to write and tie her shoes. Her speech is
excellent—that came back pretty quickly. Her personality and quirkiness came
back, too.”
Ruth’s experience, says Felling, illuminates the need for
parents and pediatricians to be well aware of the signs of stroke in children.
With an incidence of two to four per 100,000 people, Felling says, pediatric
stroke is often underrecognized, delaying diagnosis and precluding tPA
treatment for many patients who would benefit from it.
“They often don’t get to the emergency room in the time
window to be able to use it,” says Felling. “It is important to spread
awareness among physicians regarding how important time is.”
https://clinicalconnection.hopkinsmedicine.org/news/pediatric-stroke-when-tpa-is-the-best-choice?utm_medium=email&utm_source=DMD-ClinicalConnection&utm_campaign=USNews&utm_term=PediatricStroke&utm_content=PedsNeuro&aimlink=6f1ae8b4f1edf30205503ea70f445828&aimtoken=NjQ2NDExLWNiNDgxYjY1
No comments:
Post a Comment